Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard J Appleman

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Expert Opinion on Pharmacotherapy|January 28, 2010
Mifepristone: pharmacology and clinical impact in reproductive medicine, endocrinology and oncologyAnnie Im, Leonard J Appleman
Current Protocols in Immunology|April 25, 2008
In vitro models of human T cell anergyLeonard J Appleman, Vassiliki Boussiotis
Urologic Oncology|July 25, 2017
Systemic therapy following metastasectomy for renal cell carcinoma: Using insights from other clinical settings to address unanswered questionsLeonard J Appleman, Jodi K Maranchie
Immunological Reviews|April 3, 2003
T cell anergy and costimulationLeonard J Appleman, Vassiliki A Boussiotis
Cell Cycle (Georgetown, Tex.)|September 14, 2006
CD28 costimulation mediates transcription of SKP2 and CKS1, the substrate recognition components of SCFSkp2 ubiquitin ligase that leads p27kip1 to degradationLeonard J Appleman, Irina Chernova, Lequn Li, et al.
Open Access Journal of Urology|November 8, 2013
Update on vaccine development for renal cell cancerNina Chi, Jodi K Maranchie, Leonard J Appleman, et al.
Clinical Genitourinary Cancer|February 26, 2019
Sarcomatoid Renal Cell Carcinoma: Population-Based Study of 879 PatientsMichail Alevizakos, Apostolos Gaitanidis, Dimitrios Nasioudis, et al.
International Journal of Molecular Imaging|October 25, 2016
Radium-223 Therapy for Patients with Metastatic Castrate-Resistant Prostate Cancer: An Update on Literature with Case PresentationNghi C Nguyen, Muhammad Shah, Leonard J Appleman, et al.
Clinical Genitourinary Cancer|July 31, 2016
Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Practical Clinical Implications of Pharmacologic FeaturesRahul A Parikh, Leonard J Appleman, Jan H Beumer, et al.
Oncotargets and Therapy|June 25, 2014
The potential roles of hepatocyte growth factor (HGF)-MET pathway inhibitors in cancer treatmentRahul A Parikh, Peng Wang, Jan H Beumer, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Expert Opinion on Pharmacotherapy|January 28, 2010
Mifepristone: pharmacology and clinical impact in reproductive medicine, endocrinology and oncologyAnnie Im, Leonard J Appleman
Current Protocols in Immunology|April 25, 2008
In vitro models of human T cell anergyLeonard J Appleman, Vassiliki Boussiotis
Urologic Oncology|July 25, 2017
Systemic therapy following metastasectomy for renal cell carcinoma: Using insights from other clinical settings to address unanswered questionsLeonard J Appleman, Jodi K Maranchie
Immunological Reviews|April 3, 2003
T cell anergy and costimulationLeonard J Appleman, Vassiliki A Boussiotis
Cell Cycle (Georgetown, Tex.)|September 14, 2006
CD28 costimulation mediates transcription of SKP2 and CKS1, the substrate recognition components of SCFSkp2 ubiquitin ligase that leads p27kip1 to degradationLeonard J Appleman, Irina Chernova, Lequn Li, et al.
Open Access Journal of Urology|November 8, 2013
Update on vaccine development for renal cell cancerNina Chi, Jodi K Maranchie, Leonard J Appleman, et al.
Clinical Genitourinary Cancer|February 26, 2019
Sarcomatoid Renal Cell Carcinoma: Population-Based Study of 879 PatientsMichail Alevizakos, Apostolos Gaitanidis, Dimitrios Nasioudis, et al.
International Journal of Molecular Imaging|October 25, 2016
Radium-223 Therapy for Patients with Metastatic Castrate-Resistant Prostate Cancer: An Update on Literature with Case PresentationNghi C Nguyen, Muhammad Shah, Leonard J Appleman, et al.
Clinical Genitourinary Cancer|July 31, 2016
Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Practical Clinical Implications of Pharmacologic FeaturesRahul A Parikh, Leonard J Appleman, Jan H Beumer, et al.
Oncotargets and Therapy|June 25, 2014
The potential roles of hepatocyte growth factor (HGF)-MET pathway inhibitors in cancer treatmentRahul A Parikh, Peng Wang, Jan H Beumer, et al.
Pageof 7